Us Latent Tuberculosis Infection Screening Test Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Latent Tuberculosis Infection Screening Test Market was valued at USD 1.25 Billion in 2022 and is projected to reach USD 2.15 Billion by 2030, growing at a CAGR of 7.0% from 2024 to 2030.
The U.S. latent tuberculosis infection (LTBI) screening test market is experiencing significant growth, driven by increasing awareness and advancements in diagnostic technologies. In 2023, the market generated a revenue of USD 486.3 million and is projected to reach USD 637.3 million by 2030, reflecting a compound annual growth rate (CAGR) of 3.9% from 2024 to 2030. This growth is attributed to the rising prevalence of tuberculosis (TB) and the adoption of more accurate and efficient testing methods.
Latent tuberculosis infection refers to a state where individuals are infected with the TB bacteria but do not exhibit active disease symptoms. Detecting and treating LTBI is crucial to prevent the progression to active TB, which can be contagious and more challenging to treat. The primary diagnostic tools for LTBI include the Tuberculin Skin Test (TST) and Interferon Gamma Release Assays (IGRAs), such as the QuantiFERON-TB Gold Plus (QFT-Plus). These tests are essential in identifying individuals at risk and implementing preventive measures.
The market is segmented based on test type, application, and end-user. The TST and IGRAs are the main test types used for LTBI detection. Applications include household contacts with pulmonary TB, people living with HIV (PLHIV), and other at-risk populations. End-users encompass diagnostic laboratories, hospitals/clinics, and academic and research institutions. The demand for these tests is influenced by factors such as healthcare infrastructure, public health initiatives, and the prevalence of TB in specific regions.
North America, particularly the United States, holds a significant share of the LTBI screening test market. The U.S. is expected to register the highest CAGR from 2024 to 2030, driven by a large consumer base, the presence of well-established providers, and strong end-user industry demand. Leading companies in the U.S. market include Abbott, Becton, Dickinson and Company, bioMérieux, F. Hoffmann-La Roche Ltd., Lionex GmbH, Oxford Immunotec USA Inc, Sanofi, and Serum Institute of India Pvt. Ltd. These companies are focusing on new product launches and strategic partnerships to enhance their market presence and cater to the growing demand for LTBI screening tests.
In summary, the U.S. latent tuberculosis infection screening test market is poised for substantial growth, driven by technological advancements, increased awareness, and a strong healthcare infrastructure. The adoption of accurate and efficient diagnostic tools is essential in the fight against tuberculosis, aiming to reduce the incidence of active TB through early detection and preventive treatment of LTBI.
Get an In-Depth Research Analysis of the Global Latent Tuberculosis Infection Screening Test Market Size And Forecast [2025-2032]
Qiagen
Oxford Immunotec
Bio-Rad Laboratories
Thermo Fisher Scientific
Sanofi
Par Sterile
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Latent Tuberculosis Infection Screening Test Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Latent Tuberculosis Infection Screening Test Market
Interferon Gamma Release Assays (IGRAs)
Tuberculin Skin Test (TST)
Hospitals
Clinics
Diagnostic Laboratories
Home Care Settings
Screening of High-Risk Populations
Healthcare Workers Testing
Pre-Employment Screening
Screening for Patients with Comorbidities
Pediatric Population
Adult Population
Geriatric Population
Direct Sales
Wholesale Distributors
Online Sales
Medical Supply Stores
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Latent Tuberculosis Infection Screening Test Market Research Analysis
1. Introduction of the Global Latent Tuberculosis Infection Screening Test Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Latent Tuberculosis Infection Screening Test Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Latent Tuberculosis Infection Screening Test Market, By Type
6. Global Latent Tuberculosis Infection Screening Test Market, By Application
7. Global Latent Tuberculosis Infection Screening Test Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Latent Tuberculosis Infection Screening Test Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/